Variant report
Variant | esv3404839 |
---|---|
Chromosome Location | chr2:182152957-182154605 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:182152430..182154076-chr2:182155913..182157660,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs183410831 | chr2:182152979-182152980 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs577788086 | chr2:182153004-182153005 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs372316469 | chr2:182153005-182153006 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs187772803 | chr2:182153009-182153010 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs192260893 | chr2:182153011-182153012 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs184465860 | chr2:182153014-182153015 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs561946672 | chr2:182153099-182153100 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs76091616 | chr2:182153128-182153129 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs547366741 | chr2:182153167-182153168 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs189997996 | chr2:182153259-182153260 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs539513803 | chr2:182153260-182153261 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs28716233 | chr2:182153288-182153289 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs192694658 | chr2:182153292-182153293 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs535784623 | chr2:182153293-182153294 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs199992479 | chr2:182153318-182153319 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs369428437 | chr2:182153324-182153325 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs372940120 | chr2:182153365-182153366 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs556067336 | chr2:182153594-182153595 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs568546798 | chr2:182153609-182153610 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs577571504 | chr2:182153628-182153629 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs111215197 | chr2:182153632-182153633 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs374696179 | chr2:182153653-182153654 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs572645242 | chr2:182153682-182153683 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs534630442 | chr2:182153688-182153689 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs557769026 | chr2:182153690-182153691 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs574541348 | chr2:182153698-182153699 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs577826778 | chr2:182153699-182153700 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs201348662 | chr2:182153731-182153732 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs199560302 | chr2:182153814-182153815 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs543515667 | chr2:182153832-182153833 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs146184978 | chr2:182153860-182153861 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs573738187 | chr2:182153916-182153917 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs546383581 | chr2:182153922-182153923 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs542455870 | chr2:182153925-182153926 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs559628759 | chr2:182153950-182153951 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs374311901 | chr2:182154017-182154018 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs114076864 | chr2:182154026-182154027 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs559550497 | chr2:182154075-182154076 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs9630987 | chr2:182154171-182154172 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs184688524 | chr2:182154186-182154187 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs79236990 | chr2:182154193-182154194 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs564114602 | chr2:182154205-182154206 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs189208436 | chr2:182154215-182154216 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs549825316 | chr2:182154238-182154239 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs180720180 | chr2:182154262-182154263 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs541969564 | chr2:182154319-182154320 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs112435694 | chr2:182154322-182154323 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs139147112 | chr2:182154350-182154351 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs186358020 | chr2:182154371-182154372 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs566395910 | chr2:182154404-182154405 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioblastoma | 21080181 | CNVD |
Prostate cancer | 18632612 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Mental retardation | 21062444 | CNVD |
Facial dysmorphism | 20548289 | CNVD |
Mental retardation | 20548289 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:182147000-182153000 | Weak transcription | Primary T helper 17 cells PMA-I stimulated | -- |
2 | chr2:182147000-182153000 | Weak transcription | Primary T killer naive cells fromperipheralblood | blood |
3 | chr2:182147000-182159400 | Weak transcription | Thymus | Thymus |
4 | chr2:182147000-182160000 | Weak transcription | Primary T helper cells PMA-I stimulated | -- |
5 | chr2:182147800-182158200 | Weak transcription | Primary T helper naive cells from peripheral blood | blood |
6 | chr2:182148000-182159600 | Weak transcription | Primary T helper naive cells fromperipheralblood | blood |
7 | chr2:182148400-182159800 | Weak transcription | Primary T helper memory cells from peripheral blood 1 | blood |
8 | chr2:182150200-182158400 | Weak transcription | Dnd41 | blood |
9 | chr2:182150400-182158400 | Weak transcription | Primary T cells from cord blood | blood |
10 | chr2:182152600-182153000 | Enhancers | Primary T killer memory cells from peripheral blood | blood |
11 | chr2:182153000-182153200 | Enhancers | Primary T helper 17 cells PMA-I stimulated | -- |
12 | chr2:182153000-182153200 | Enhancers | Primary T killer naive cells fromperipheralblood | blood |
13 | chr2:182153000-182164000 | Weak transcription | Primary T killer memory cells from peripheral blood | blood |
14 | chr2:182153800-182159200 | Weak transcription | Primary mononuclear cells fromperipheralblood | Blood |